NACO Startup Genome Report - Canada's Funding Gaps 030426

6.2.3.​ Total Series B+ funding

3 year deal period

Canada Tier 1

Canada Tier 2

US Tier 1

US Tier 2

2011-13

$1,322,158,678

$151,958,639

$14,132,583,890

$7,192,370,930

2014-16

$3,711,686,334

$221,553,328

$29,587,931,847

$9,774,143,606

2017-19

$6,724,081,984

$735,320,132

$42,346,530,525

$12,992,819,730

2020-22

$15,096,702,650

$1,230,328,888

$83,761,497,368

$25,492,262,015

2023-24

$5,485,141,327

$1,684,389,692

$31,198,671,939

$8,372,546,433

Grand Total

$33,292,165,725

$4,083,036,219

$216,108,389,200

$71,436,659,667

6.3.​ Median size of rounds 6.3.1.​ Median seed rounds The following table illustrates the median size of seed rounds. (These are shown as three year moving averages):

US Tier 1

US Tier 2

Canada Tier 1

Canada Tier 2

2011-2013

$741,820

$656,667

$626,748

$841,792

2012-2014

$816,667

$730,000

$710,082

$741,792

2013-2015

$900,000

$850,063

$665,000

$676,667

2014-2016

$966,667

$916,730

$729,690

$610,000

2015-2017

$1,040,569

$993,396

$796,357

$640,947

2016-2018

$1,123,903

$1,083,333

$831,357

$730,947

2017-2019

$1,207,236

$1,216,667

$916,667

$818,822

2018-2020

$1,266,667

$1,383,333

$933,333

$758,798

2019-2021

$1,383,333

$1,437,500

$1,066,667

$824,123

2020-2022

$1,636,667

$1,470,833

$1,193,755

$965,358

2021-2023

$1,936,667

$1,564,167

$1,268,755

$1,377,768

2022-2024

$2,236,667

$1,760,000

$1,368,755

$1,652,509

Startup Genome | San Francisco • Berlin • London • Delhi • Tokyo • Abu Dhabi • Bangalore • São Paulo ​

p. 50

Powered by